Medication Used to Control Blood Sugar in People with Type 2 Diabetes May Also Reduce the Risk of Autoimmune Diseases
American College of Rheumatology (ACR)Dipeptidyl peptidase-4 inhibitors commonly used to control blood sugar levels in people with type 2 diabetes may also reduce the risk of autoimmune diseases in these patients, according to research presented this week at the American College of Rheumatology Annual Meeting in San Diego.